Archive for the ‘Review’ Category

Review: Muscle pain due to statins

Friday, July 3rd, 2009

Statins are probably the best medications to reduce cholesterol level and also have associated anti-inflammatory activities. Both these properties lead to a marked decrease in atherosclerosis and related diseases.

Muscle pain is quite common in people (up to 10%) who take one of the several statins for lowering their cholesterol levels. However, there is no strict consensus on how to define, diagnose and manage such muscle pains.

The Annals of Internal Medicine recently published an excellent review on “Statin related myopathy.” Here is a brief summary of the article.

Definition:

There is no consensus definition. Each group (ACC/AHA, FDA etc) have their own definitions. For most clinical purposes the following definitions should be adequate:

Myopathy: Muscle disease with creatine kinase > 10 time upper limit

Rhabdomyolysis: Creatine kinase elevation with end organ damage

Pathophysiology:

Incompletely understood. Proposed mechanisms include:

  1. Decreased cholesterol content of skeletal myocyte membrane leading to instabilty
  2. Depletion of isoprenoids and/or coenzyme Q10
  3. Mitochondrial dysfunction

Risk factors for developing myopathy:

  • Advanced age
  • Smaller body size
  • Multi-system diseases (including hypothyroidism)
  • Alcoholism
  • Major surgery, excess physical activity
  • History of myopathy while on other lipid lowering agent
  • Family history
  • Higher doses of statin
  • Interaction with other drugs leading to increased bio-availability of statins

Clinical Features:

Major site of muscle pain were in the thighs, calves or it was generalized. Pain was described as heaviness, stiffness or cramping and sometimes was associated with exertion. Physical exertion was a common trigger of myalgia. Tendon pain may also be present.

Management:

  • Check creatine kinase (CK) levels in high risk patients
  • If CK levels > 10 times upper limit, stop statin
  • Re-initiate statin with a lower dose once CK levels return to normal
  • Try switching to fluvastain (better tolerated) or rosuvastatin (less interaction with other medications)
  • Atorvastatin and Rosuvastatin have long half life and can be administered on alternate days
  • Trial of other lipid lowering agents (e.g. Bile acid binders, ezetimibe, niacin etc)
  • Co-enzyme Q10 supplementation may tried. No clear benefit but is very safe.

Swine Flu

Monday, June 22nd, 2009

Since we are still in midst of the swine flu (H1N1) pandemic - here is a quick summary and useful links:

“In this video, Dr. Joe Bresee with the CDC Influenza Division describes swine flu - its signs and symptoms, how it’s transmitted, medicines to treat it, steps people can take to protect themselves from it, and what people should do if they become ill.”


Map: Weekly Influenza Activity Estimates Reported by State and Territorial Epidemiologists


swine_flu_map.jpg


Swine Flu Cases per million population by country:

(Data taken from The Guardian - Data Blog)

Cases per Million Population by Country


Useful Links:
Center of Disease Control
Swine Flu update RSS feed from CDC
WHO - Epidemic and Pandemic Alert and Response
New England Journal of Medicine H1N1 Influenza Center
Lancet - H1N1 Flu Resource Center
Nature specials - Swine Flu

Surgery’s past, present and robotic future

Thursday, June 18th, 2009

Another excellent talk at TED:

“Surgeon and inventor Catherine Mohr tours the history of surgery (and its pre-painkiller, pre-antiseptic past), then demos some of the newest tools for surgery through tiny incisions, performed using nimble robot hands. Fascinating — but not for the squeamish.”


The Story of Malaria

Wednesday, June 10th, 2009

Malaria is a mosquito borne illness caused by the female anopheles mosquito. Each year 350-500 million cases of malaria occur worldwide, and over one million people die, most of them young children in Africa south of the Sahara (CDC).

The British Medical Journal has uploaded a 10 minute YouTube video (Death by Mosquito) on the origins of malaria as we understand it now. Prior to the paper published in the BMJ in 1900, malaria was thought to be an airborne infection (mal = foul).

In 1900 Patrick Manson wrote a seminal paper in the BMJ Experimental Proof of the Mosquitomalaria Theory he worked closely with Ronald Ross, who went on to win the Nobel Prize for medicine for his work on malaria.


Thromboangiitis Obliterans

Monday, March 23rd, 2009

(Double click any word for definition)

Also known as Buerger’s Disease (not to be confused with Berger’s disease which is IgA nephropathy)

Small - medium sized blood vessels involved

Strongly linked to tobacco use - smoking (both active and passive) and nicotine patches

Unclear etiology

More common in men than women (3:1)

Typical age group 20 - 45 years


Clinical Features

Diagnosis of exclusion

Typically age is < 45 years

Current or history of tobacco use

Presence of distal extremity ischemia (indicated by claudication, pain at rest, ischemic ulcers, or gangrene) documented by noninvasive vascular testing

Consistent arteriographic findings in the clinically involved and noninvolved limbs

Patients may describe a Raynaud type phenomenon in hands or fingers

Superficial migratory thrombophlebitis may occur

Parasthesias of hands & feet with impaired distal pulses (proximal pulses are generally normal)

Allen test may be positive


Workup

Labs are typically geared towards ruling out other causes

Angiography - may be required in all limbs as TAO may be clinically silent

Typical angiography features include:

  • Nonatherosclerotic
  • Segmental
  • Involvement of small- and medium-sized vessels
  • Formation of distinctive small-vessel collaterals around areas of occlusion known as “corkscrew collaterals”

Echo should always be performed to rule out embolic source


Treatment

Absolute discontinuation of tobacco use

Symptomatic management

  • Protective footwear
  • Avoid injuries and cold
  • Avoid medications which cause vasoconstriction

Surgical options:

  • Due to involvement of small vessels bypass grafting has limited value
  • Omental transfer
  • Sympathectomy
  • Spinal cord stimulator implantation